サンプル依頼リスト カート
  • English
  • Korean
市場調査レポート
商品コード
1596083

医薬品の世界市場、2033年までの機会と戦略

Pharmaceutical Drugs Global Market Opportunities And Strategies To 2033

出版日
ページ情報
英文 527 Pages
納期
2～3営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=157.50円
医薬品の世界市場、2033年までの機会と戦略
出版日: 2024年11月21日
発行: The Business Research Company
ページ情報: 英文 527 Pages
納期: 2～3営業日
  • 全表示
  • 概要
  • 目次
概要

世界の医薬品市場は2018年に1兆1,631億4,000万米ドルと評価され、2023年までCAGR6.00%以上で成長しました。

高いヘルスケア意識

歴史的な期間中、高いヘルスケア意識が医薬品市場の成長を支えました。健康を維持し病気を予防することの重要性に対する意識が高まるにつれ、ワクチンやサプリメントを含む予防薬への需要が高まった。このような消費者の意識の変化が、疾病予防のための医薬品使用の増加を後押ししました。例えばオーストラリアでは、オーストラリア政府の独立法定機関であるオーストラリア統計局によると、2020-21年と比較して、2021-2022年にはより多くの人が医療サービスを利用し、GP（一般開業医）を受診（83.6％対82.4％）、歯科医を受診（49.4％対47.9％）、医師を受診（38.9％対37.4％）、病院の救急部（ED）を受診（14.8％対13.4％）しています。したがって、高いヘルスケア意識が医薬品需要を押し上げ、これが歴史的な期間中の医薬品市場を牽引しました。

目次

第1章 エグゼクティブサマリー

  • 医薬品-市場の魅力とマクロ経済情勢

第2章 目次

第3章 表一覧

第4章 図一覧

第5章 レポート構成

第6章 市場の特徴

  • 一般的な市場の定義
  • 概要
  • 医薬品市場定義とセグメンテーション
  • 市場セグメンテーション：タイプ別
    • 心臓血管薬
    • 皮膚科用薬
    • 胃腸薬
    • 泌尿器科用薬
    • 血液学薬
    • 抗感染薬
    • 代謝障害薬
    • 筋骨格障害薬
    • 中枢神経系薬
    • 腫瘍治療薬
    • 眼科用薬
    • 呼吸器疾患薬
    • ワクチン
    • 治療用栄養素とミネラル
  • 市場セグメンテーション：流通チャネル別
    • 病院薬局
    • 小売薬局/ドラッグストア
    • その他の流通チャネル
  • 市場セグメンテーション：投与経路別
    • 経口
    • 非経口
    • その他の投与経路
  • 市場セグメンテーション：医薬品分類別
    • ブランド医薬品
    • ジェネリック医薬品
  • 市場セグメンテーション：購入方法別
    • 市販薬
    • 処方薬

第7章 医薬品市場、製品/サービス分析-製品/サービスの例

第8章 医薬品市場、サプライチェーン分析

  • サプライチェーン
    • 原材料サプライヤー
    • 調査受託機関（CRO）
    • 医薬品メーカー
    • 契約製造組織（CMO）
  • 流通
    • 卸売業者/販売業者
    • 小売店（薬局）と病院
    • 医師
  • エンドユーザー

第9章 顧客情報

  • 緊急時以外のケアでは地元の薬局が好まれる傾向が高まっている
  • 処方薬を頻繁に服用する人々の経済的苦境
  • インドの消費者におけるジェネリック医薬品に対する肯定的な認識
  • 様々な治療分野における必須医薬品の広範な不足
  • がん患者は製薬会社の支援を必要としている
  • 薬局環境への嗜好の高まり
  • 健康とフィットネスへの注目が高まる
  • 農村と都市のコミュニティにおけるCOVID-19の拡散抑制におけるワクチンの有効性に関する認識
  • アメリカ人はオンライン薬局よりも実店舗の薬局を好む

第10章 主要な市場動向

  • 医薬品生産の増強に向けた注射剤および生物製剤製造施設への投資
  • 医薬品開発を加速させる先進技術に注目
  • より幅広い患者アクセスを可能にするジェネリックがん治療薬の開発
  • 医薬品開発におけるバイオマーカーの利用
  • 治療を高めるため、個別化医療への注目が高まる
  • 医薬品発見のための人工知能（AI）への投資
  • 主要企業間の戦略的パートナーシップとコラボレーション

第11章 医薬品市場：マクロ経済シナリオ

  • COVID-19の影響：医薬品市場
  • ウクライナ戦争の影響：医薬品市場
  • 高インフレの影響：医薬品市場

第12章 世界の市場規模と成長

  • 市場規模
  • 市場成長実績, 2018-2023
    • 市場促進要因2018-2023
    • 市場抑制要因2018-2023
  • 市場成長予測, 2023-2028, 2033F
    • 市場促進要因2023-2028
    • 市場抑制要因2023-2028

第13章 医薬品市場：地域別分析

  • 世界の医薬品市場：地域別、実績と予測, 2018-2023, 2028F, 2033F
  • 世界の医薬品市場：地域別、成長と市場シェアの比較, 2023-2028

第14章 世界の医薬品市場：セグメンテーション

  • 世界の医薬品市場：タイプ別、実績と予測, 2018-2023, 2028F, 2033F
  • 世界の医薬品市場：流通チャネル別、実績と予測, 2018-2023, 2028F, 2033F
  • 世界の医薬品市場：投与経路別、実績と予測, 2018-2023, 2028F, 2033F
  • 世界の医薬品市場：医薬品分類別、実績と予測, 2018-2023, 2028F, 2033F
  • 世界の医薬品市場：購入方法別、実績と予測, 2018-2023, 2028F, 2033F

第15章 医薬品市場サブセグメント

  • 世界の心臓血管薬市場タイプ別、実績と予測, 2018-2023, 2028F, 2033F
  • 世界の皮膚科用薬市場タイプ別、実績と予測, 2018-2023, 2028F, 2033F
  • 世界の胃腸薬市場タイプ別、実績と予測, 2018-2023, 2028F, 2033F
  • 世界の泌尿器科用薬市場タイプ別、実績と予測, 2018-2023, 2028F, 2033F
  • 世界の血液学薬市場タイプ別、実績と予測, 2018-2023, 2028F, 2033F
  • 世界の抗感染薬市場タイプ別、実績と予測, 2018-2023, 2028F, 2033F
  • 世界の代謝障害薬市場タイプ別、実績と予測, 2018-2023, 2028F, 2033F
  • 世界の筋骨格障害薬市場タイプ別、実績と予測, 2018-2023, 2028F, 2033F
  • 世界の中枢神経系薬市場タイプ別、実績と予測, 2018-2023, 2028F, 2033F
  • 世界の腫瘍治療薬市場タイプ別、実績と予測, 2018-2023, 2028F, 2033F
  • 世界の眼科用薬市場タイプ別、実績と予測, 2018-2023, 2028F, 2033F
  • 世界の呼吸器疾患薬市場タイプ別、実績と予測, 2018-2023, 2028F, 2033F
  • 世界のワクチン市場タイプ別、実績と予測, 2018-2023, 2028F, 2033F
  • 世界の治療用栄養素とミネラル市場タイプ別、実績と予測, 2018-2023, 2028F, 2033F

第16章 マクロ経済要因別市場比較

  • 医薬品市場規模、GDPの割合、世界
  • 医薬品市場の一人当たりの平均支出,世界

第17章 アジア太平洋市場

第18章 西欧市場

第19章 東欧市場

第20章 北米市場

第21章 南米市場

第22章 中東市場

第23章 アフリカ市場

第24章 競合情勢と企業プロファイル

  • 企業プロファイル
  • Pfizer Inc
  • Johnson & Johnson
  • AbbVie Inc
  • Merck & Co., Inc.
  • F. Hoffman-La Roche Ltd

第25章 その他の大手企業と革新的企業

  • AstraZeneca Plc
  • Novartis AG
  • Bristol-Myers Squibb Company
  • Sanofi S.A
  • GSK plc
  • Novo Nordisk A/S
  • Eli Lilly and Company
  • Takeda Pharmaceutical Company Limited
  • Amgen Inc
  • Gilead Sciences Inc
  • C.H. Boehringer Sohn AG & Co. KG
  • Bayer AG
  • Teva Pharmaceutical Industries Ltd
  • CSL Limited
  • Daiichi Sankyo Company, Limited

第26章 競合ベンチマーキング

第27章 競合ダッシュボード

第28章 主要な合併と買収

  • Ceres Pharma NV Acquired Innopharm Kft
  • Abbott Laboratories Acquired Bigfoot Biomedical
  • Novo Nordisk Acquired Inversago Pharma
  • Biogen Acquired Reata Pharmaceuticals
  • Eli Lilly Acquired Dice Therapeutics
  • Recursion Pharmaceuticals Acquired Cyclica and Valance
  • GSK Acquired Bellus Health
  • Sanofi Acquired Provention Bio
  • Pfizer Acquired Seagen
  • Leap Therapeutics, Inc. Merged With Flame Biosciences, Inc.
  • Sun Pharmaceutical Industries Acquired Concert Pharma
  • GSK PLC Acquired Sierra Oncology Inc
  • Bora Pharmaceuticals Acquired Eden Biologics
  • GSK plc Acquired Affinivax, Inc
  • Piramal Pharma Acquired Hemmo Pharmaceuticals
  • Ethypharm Acquired Altan Pharma
  • Jazz Pharmaceuticals Acquired GW Pharmaceuticals Plc
  • Sanofi SA Acquired Tidal Therapeutics
  • Merck & Co Acquired Pandion Therapeutics
  • Horizon Therapeutics Acquired Viela Bio

第29章 機会と戦略

  • 世界の医薬品市場2028：新たな機会を提供する国
  • 世界の医薬品市場2028：新たな機会を提供するセグメント
  • 世界の医薬品市場2028：成長戦略
    • 市場動向に基づく戦略
    • 競合の戦略

第30章 医薬品市場：結論と提言

  • 結論
  • 提言
    • 製品
    • 場所
    • 価格
    • プロモーション
    • 人

第31章 付録

目次
Product Code: o&s1394

Pharmaceutical drugs are substances used to prevent, treat or cure diseases or ailments, or to alleviate their symptoms. Pharmaceutical companies produce pharmaceutical drugs made from active pharmaceutical ingredients (API) and excipients.

The pharmaceutical drug market consists of sales of pharmaceutical drugs by entities (organizations, sole traders and partnerships) that produce and sell pharmaceutical drugs or biologics used to treat various diseases. This industry includes establishments that produce drugs such as cardiovascular drugs, gastrointestinal drugs, genito-urinary drugs, hematology drugs and other drugs used to treat cardiovascular diseases, rare genetic disorders, infections, metabolic disorders, cancers, respiratory diseases and others.

The global pharmaceutical drugs market was valued at $1,163.14 billion in 2018 which grew till 2023 at a compound annual growth rate (CAGR) of more than 6.00%.

High Healthcare Awareness

During the historic period, the high healthcare awareness supported the growth of the pharmaceutical drugs market. As awareness of the importance of maintaining good health and preventing diseases grew, demand for preventive medications, including vaccines and supplements, rose. This shift in consumer mindset drove the increased use of pharmaceutical drugs for disease prevention. For example, in Australia, according to the Australian Bureau Of Statistics, the independent statutory agency of the Australian Government, in comparison to 2020-21, more people used health services in 2021-2022, people visited a GP (general practitioner) (83.6% versus 82.4%), visited a dentist (49.4% as opposed to 47.9%), visited a doctor (38.9% as opposed to 37.4%), visited an emergency department (ED) at a hospital (14.8% as opposed to 13.4%). Therefore, the high healthcare awareness boosted the demand for drugs and medicines and this drove the pharmaceutical drugs market during the historic period.

Investments In Injectable And Biologics Manufacturing Facilities To Boost Pharmaceutical Drug Production

Companies in the pharmaceutical drugs market are investing in injectable and biologics manufacturing facilities to boost pharmaceutical drug production. For instance, in August 2024, Vivint Pharma, an India-based pharmaceutical company that provides pharmaceutical drugs, has announced a substantial investment of approximately $48.2 million (INR 400 million) to establish a new injectable manufacturing facility in Genome Valley, Hyderabad, India. This facility is expected to create around 1,000 jobs and will focus on producing high-quality injectable drugs, particularly in oncology and critical care, serving both domestic and international markets. This investment builds on Vivint Pharma's prior commitment of $8.4 million (INR 70 million) for its research and development center in the same region. The company has acquired 5.5 acres of land for this project, which aims to enhance the pharmaceutical manufacturing capabilities of the area. Additionally, in January 2024, AbbVie, a US-based pharmaceutical company that provides pharmaceutical drugs, has announced a substantial investment of $223 million to expand its biologics manufacturing facility in Singapore. This expansion aims to increase the plant's capacity by adding 24,000 liters of biologics drug substance capacity, thereby supporting AbbVie's growing pipeline of treatments for conditions such as immunology and oncology.

The global pharmaceutical drugs market is concentrated, with large players operating in the market. The top ten competitors in the market made up to 30.31% of the total market in 2023.

Pharmaceutical Drugs Global Market Opportunities And Strategies To 2033 from The Business Research Company provides the strategists; marketers and senior management with the critical information they need to assess the global pharmaceutical drugs market as it emerges from the COVID-19 shut down.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 50 geographies.
  • Understand how the market is being affected by the coronavirus and how it is likely to emerge and grow as the impact of the virus abates.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market research findings.
  • Benchmark performance against key competitors.
  • Utilize the relationships between key data sets for superior strategizing.
  • Suitable for supporting your internal and external presentations with reliable high-quality data and analysis.

Where is the largest and fastest-growing market for pharmaceutical drugs? How does the market relate to the overall economy; demography and other similar markets? What forces will shape the market going forward? The pharmaceutical drugs market global report from The Business Research Company answers all these questions and many more.

The report covers market characteristics; size and growth; segmentation; regional and country breakdowns; competitive landscape; market shares; trends and strategies for this market. It traces the market's history and forecasts market growth by geography. It places the market within the context of the wider pharmaceutical drugs market; and compares it with other markets.

The report covers the following chapters

  • Introduction and Market Characteristics- Brief introduction to the segmentations covered in the market, definitions and explanations about the segment by type, by distribution channel, by route of administration, by drug classification and by mode of purchase.

Product Analysis The product analysis section of the report describes the leading products in the pharmaceutical drugs market, along with key features and differentiators for those products.

Supply Chain The supply chain section of the report defines and explains the key players in the pharmaceutical drugs industry supply chain.

Customer Information The chapter covers recent customer trends/preferences in the global pharmaceutical drugs market.

  • Key Trends- Highlights the major trends shaping the global market. This section also highlights likely future developments in the market.
  • Macro-Economic Scenario- The report provides an analysis of the impact of the COVID-19 pandemic, impact of the Russia-Ukraine war and impact of rising inflation on global and regional markets, providing strategic insights for businesses in the pharmaceutical drugs market.
  • Global Market Size And Growth- Global historic (2018-2023) and forecast (2023-2028, 2033F) market values and drivers and restraints that support and control the growth of the market in the historic and forecast periods.
  • Regional And Country Analysis- Historic (2018-2023) and forecast (2023-2028, 2033F) market values and growth and market share comparison by region and country.
  • Market Segmentation- Contains the market values (2018-2023) (2023-2028, 2033F) and analysis for each segment by type, by distribution channel, by route of administration, by drug classification and by mode of purchase in the market. Historic (2018-2023) and forecast (2023-2028) and (2028-2033) market values and growth and market share comparison by region market.
  • Regional Market Size and Growth- Regional market size (2023), historic (2018-2023) and forecast (2023-2028, 2033F) market values and growth and market share comparison of countries within the region. This report includes information on all the regions Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa and major countries within each region.
  • Competitive Landscape- Details on the competitive landscape of the market, estimated market shares and company profiles of the leading players.
  • Other Major And Innovative Companies Details on the company profiles of other major and innovative companies.
  • Competitive Benchmarking- Briefs on the financials comparison between major players in the market.
  • Competitive Dashboard- Briefs on competitive dashboard of major players.
  • Key Mergers and Acquisitions- Information on recent mergers and acquisitions in the market is covered in the report. This section gives key financial details of mergers and acquisitions which have shaped the market in recent years.
  • Market Opportunities And Strategies- Describes market opportunities and strategies based on findings of the research, with information on growth opportunities across countries, segments and strategies to be followed in those markets.
  • Conclusions And Recommendations- This section includes recommendations for pharmaceutical drugs providers in terms of product/service offerings geographic expansion, marketing strategies and target groups.
  • Appendix- This section includes details on the NAICS codes covered, abbreviations and currencies codes used in this report.

Markets Covered:

  • 1) By Type: Cardiovascular Drugs; Dermatology Drugs; Gastrointestinal Drugs; Genito-Urinary Drugs; Hematology Drugs; Anti-Infective Drugs; Metabolic Disorder Drugs; Musculoskeletal Disorder Drugs; Central Nervous System Drugs; Oncology Drugs; Ophthalmology Drugs; Respiratory Disease Drugs; Vaccine; Therapeutic Nutrients And Minerals
  • a) Cardiovascular Drugs Type: Anti-Hypertensive Drugs; Hypolipidemics; Anti-Thrombotic; Angina Pectoris; Congestive Heart Failure; Other Cardiovascular Drugs
  • b) Dermatology Drugs Type: Acne Drugs; Dermatitis Drugs; Psoriasis Drugs; Other Drugs For Dermatology Diseases
  • c) Gastrointestinal Drugs Type: Antacids; Antiulcerants; Antiemetics And Antinauseants; Antidiarrheals
  • d) Genito-Urinary Drugs Type: Hormonal Contraceptives; Drugs For Benign Prostatic Hypertrophy, Drugs For Infertility; Drugs For Erectile Dysfunction; Drugs For Urinary Incontinence And Overactive Bladder; Drugs For Infections And Others; Drugs For Hormonal Replacement Therapy; Diuretics
  • e) Hematology Drugs Type: Blood Products And Anemia; Other Blood Disorder Drugs
  • f) Anti-Infective Drugs: Type: Antibiotics; Antivirals; Antifungals; Others (Anthelminthic, Antiprotozoal)
  • g) Metabolic Disorders Drugs Type: Anti-Diabetic Drugs; Anti-Thyroid Drugs; Anti-Obesity; Others
  • h) Musculoskeletal Disorders Type: Drugs For Rheumatoid Arthritis; Muscle Relaxants; Other Musculoskeletal Disorders Drugs
  • i) Central Nervous System Drugs Type: Analgesics; Anti-Parkinson Drugs; Anesthetics; Anti-Epileptics; Alzheimer; Other CNS Drugs
  • j) Oncology Drugs Type: Lung Cancer Drugs; Pancreatic Cancer Drugs; Breast Cancer Drugs; Prostate Cancer Drugs; Ovarian Cancer Drugs; Colorectal Cancer Drugs; Gastric Cancer Drugs; Kidney Cancer Drugs; Brain Tumor Drugs; Thyroid Cancer Drugs; Skin Cancer Drugs; Bladder Cancer Drugs; Cervical Cancer Drugs; Hematopoietic Cancer Drugs; Others
  • k) Ophthalmology Drugs Type: Antiglaucoma Drugs; Dry Eye Medication; Other Ophthalmology Drugs
  • l) Respiratory Diseases Drugs Type: Anti-Asthmatics And COPD Drugs; Cough And Cold Preparations
  • m) Vaccine Market Is Type: Therapeutic Vaccines; Preventive Vaccines

n) Therapeutic Nutrients And Minerals Type: Electrolytes; Minerals And Vitamins

  • 2) By Route Of Administration: Oral; Parenteral; Other Route Of Administration
  • 3) By Drug Classification: Branded Drugs; Generic Drugs
  • 4) By Distribution Channel: Hospital Pharmacies; Retail Pharmacies/ Drug Stores; Other Distribution Channels
  • Companies Mentioned: Pfizer Inc.; Johnson & Johnson; AbbVie Inc.; Merck & Co., Inc.; F. Hoffmann-La Roche AG
  • Countries: China; Australia; India; Indonesia; Japan; South Korea; Bangladesh; Thailand; Vietnam, Malaysia; Singapore; Philippines; Hong Kong; New Zealand; USA; Canada; Brazil; Mexico; France; Germany; UK; Austria; Belgium; Denmark; Finland; Ireland; Italy; Netherlands; Norway; Portugal; Spain; Sweden; Switzerland; Russia; Czech Republic; Poland; Romania; Ukraine; Chile; Argentina; Colombia; Peru; Saudi Arabia; Israel; Iran; Turkey; UAE; Egypt; Nigeria; South Africa
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time-series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets; GDP proportions; expenditure per capita; pharmaceutical drugs indicators comparison.
  • Data segmentations: country and regional historic and forecast data; market share of competitors; market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.

Table of Contents

1 Executive Summary

  • 1.1 Pharmaceutical Drugs - Market Attractiveness And Macro Economic Landscape

2 Table Of Contents

3 List Of Tables

4 List Of Figures

5 Report Structure

6 Market Characteristics

  • 6.1 General Market Definition
  • 6.2 Summary
  • 6.3 Pharmaceutical Drugs Market Definition And Segmentations
  • 6.4 Market Segmentation By Type
    • 6.4.1 Cardiovascular Drugs
    • 6.4.2 Dermatology Drugs
    • 6.4.3 Gastrointestinal Drugs
    • 6.4.4 Genito-Urinary Drugs
    • 6.4.5 Hematology Drugs
    • 6.4.6 Anti-Infective Drugs
    • 6.4.7 Metabolic Disorders Drugs
    • 6.4.8 Musculoskeletal Disorders Drugs
    • 6.4.9 Central Nervous System Drugs
    • 6.4.10 Oncology Drugs
    • 6.4.11 Ophthalmology Drugs
    • 6.4.12 Respiratory Diseases Drugs
    • 6.4.13 Vaccine
    • 6.4.14 Therapeutic Nutrients And Minerals
  • 6.5 Market Segmentation By Distribution Channel
    • 6.5.1 Hospital Pharmacies
    • 6.5.2 Retail Pharmacies/ Drug Stores
    • 6.5.3 Other Distribution Channels
  • 6.6 Market Segmentation By Route Of Administration
    • 6.6.1 Oral
    • 6.6.2 Parenteral
    • 6.6.3 Other Route Of Administration
  • 6.7 Market Segmentation By Drug Classification
    • 6.7.1 Branded Drugs
    • 6.7.2 Generic Drugs
  • 6.8 Market Segmentation By Mode Of Purchase
    • 6.8.1 Over-The-Counter-Drugs
    • 6.8.2 Prescription-Based Drugs

7 Pharmaceutical Drugs Market, Product/Service Analysis -Product/Service Examples

8 Pharmaceutical Drugs Market, Supply Chain Analysis

  • 8.1 Supply Chain
    • 8.1.1 Raw Material Suppliers
    • 8.1.2 Contract Research Organization (CRO)
    • 8.1.3 Pharmaceutical Drug Manufacturers
    • 8.1.4 Contract Manufacturing Organization (CMO)
  • 8.2 Distribution
    • 8.2.1 Wholesalers/Distributors
    • 8.2.2 Retailers (Pharmacies) and Hospitals
    • 8.2.3 Physicians/Doctors
  • 8.3 End-Users

9 Customer Information

  • 9.1 Increased Preference For Local Pharmacies For Non-Emergency Care
  • 9.2 Financial Struggles Among High-Usage Prescription Medication Users
  • 9.3 Positive Perception Of Generic Drugs Among Indian Consumers
  • 9.4 Widespread Scarcity Of Essential Medicines Across Various Therapeutic Categories
  • 9.5 Cancer Patients Are In Need Of Pharma's Support
  • 9.6 Increasing Preference Towards Pharmacy Settings
  • 9.7 Increasing Focus On Health And Fitness
  • 9.8 Perception Towards Vaccine Effectiveness In Controlling COVID-19 Spread In Rural And Urban Communities
  • 9.9 Americans Prefer Retail Pharmacies Over Online Pharmacies

10 Major Market Trends

  • 10.1 Investments In Injectable And Biologics Manufacturing Facilities To Boost Pharmaceutical Drug Production
  • 10.2 Focus On Advanced Technologies To Accelerate Drug Development
  • 10.3 Development Of Generic Cancer Drugs To Enable Broader Patient Access
  • 10.4 Use Of Biomarkers For Drug Development
  • 10.6 Increased Focus On Personalized Medicine To Enhance Treatment
  • 10.7 Investment In Artificial Intelligence (AI) For Drugs Discovery
  • 10.8 Strategic Partnerships And Collaborations Among Major Players

11 Pharmaceutical Drugs Market - Macro Economic Scenario

  • 11.1 COVID-19 Impact On The Pharmaceutical Drugs Market
  • 11.2 Impact Of The War In Ukraine On The Pharmaceutical Drugs Market
  • 11.3 Impact Of High Inflation On The Pharmaceutical Drugs Market

12 Global Market Size And Growth

  • 12.1 Market Size
  • 12.2 Historic Market Growth, 2018 - 2023, Value ($ Billion)
    • 12.2.1 Market Drivers 2018 - 2023
    • 12.2.2 Market Restraints 2018 - 2023
  • 12.3 Forecast Market Growth, 2023 - 2028, 2033F Value ($ Billion)
    • 12.3.1 Market Drivers 2023 - 2028
    • 12.3.2 Market Restraints 2023 - 2028

13 Pharmaceutical Drugs Market, Regional Analysis

  • 13.1 Global Pharmaceutical Drugs Market, By Region, Historic and Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Billion)
  • 13.2 Global Pharmaceutical Drugs Market, 2018 - 2028, Historic And Forecast, By Region
  • 13.3 Global Pharmaceutical Drugs Market, 2023 - 2028, Growth And Market Share Comparison, By Region

14 Global Pharmaceutical Drugs Market Segmentation

  • 14.1 Global Pharmaceutical Drugs Market, Segmentation By Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Billion)
  • 14.2 Global Pharmaceutical Drugs Market, Segmentation By Distribution Channel, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Billion)
  • 14.3 Global Pharmaceutical Drugs Market, Segmentation By Route Of Administration, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Billion)
  • 14.4 Global Pharmaceutical Drugs Market, Segmentation By Drug Classification, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Billion)
  • 14.5 Global Pharmaceutical Drugs Market, Segmentation By Mode Of Purchase, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Billion)

15 Pharmaceutical Drugs Market Sub-Segment

  • 15.1 Global Cardiovascular Drugs Market, Segmentation By Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Billion)
  • 15.2 Global Dermatology Drugs Market, Segmentation By Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Billion)
  • 15.3 Global Gastrointestinal Drugs Market, Segmentation By Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Billion)
  • 15.4 Global Genito-Urinary Drugs Market, Segmentation By Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Billion)
  • 15.5 Global Hematology Drugs Market, Segmentation By Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Billion)
  • 15.6 Global Anti-Infective Drugs Market, Segmentation By Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Billion)
  • 15.7 Global Metabolic Disorders Drugs Market, Segmentation By Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Billion)
  • 15.8 Global Musculoskeletal Disorders Drugs Market, Segmentation By Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Billion)
  • 15.9 Global Central Nervous System Drugs Market, Segmentation By Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Billion)
  • 15.10 Global Oncology Drugs Market, Segmentation By Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Billion)
  • 15.11 Global Ophthalmology Drugs Market, Segmentation By Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Billion)
  • 15.12 Global Respiratory Diseases Drugs Market, Segmentation By Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Billion)
  • 15.13 Global Vaccine Market, Segmentation By Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Billion)
  • 15.14 Global Therapeutic Nutrients And Minerals Market, Segmentation By Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Billion)

16 Market Comparison with Macro Economic Factors

  • 16.1 Pharmaceutical Drugs Market Size, Percentage Of GDP, Global
  • 16.2 Per Capita Average Pharmaceutical Drugs Market Expenditure, Global

17 Asia-Pacific Market

  • 17.1 Summary
  • 17.2 Market Overview
    • 17.2.1 Region Information
    • 17.2.2 Market Information
    • 17.2.3 Background Information
    • 17.2.4 Government Initiatives
    • 17.2.5 Regulations
    • 17.2.6 Regulatory Bodies
    • 17.2.7 Major Associations
    • 17.2.8 Taxes Levied
    • 17.2.9 Corporate Tax Structure
    • 17.2.10 Investments
    • 17.2.11 Major Companies
  • 17.3 Asia-Pacific Pharmaceutical Drugs Market, Segmentation By Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Billion)
  • 17.4 Asia-Pacific Pharmaceutical Drugs Market, Segmentation By Distribution Channel, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Billion)
  • 17.5 Asia-Pacific Pharmaceutical Drugs Market, Segmentation By Route Of Administration, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Billion)
  • 17.6 Asia-Pacific Pharmaceutical Drugs Market, 2023, By Country, Value ($ Billion)
  • 17.7 Asia-Pacific Pharmaceutical Drugs Market, 2018 - 2028, Historic And Forecast, By Country
  • 17.8 Asia-Pacific Pharmaceutical Drugs Market, 2023 - 2028, Growth And Market Share Comparison, By Country
  • 17.9 Asia-Pacific Pharmaceutical Drugs Market Metrics
    • 17.9.1 Per Capita Pharmaceutical Drugs Expenditure, 2023, Asia-Pacific Major Countries
    • 17.9.2 Estimated Number Of Employees, Pharmaceutical Drugs Market, 2023, Asia-Pacific Countries
  • 17.10 Asia-Pacific Pharmaceutical Drugs Market: Country Analysis
  • 17.11 Australia Market
  • 17.12 Australia Pharmaceutical Drugs Market, Segmentation By Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F Value ($ Billion)
  • 17.13 Australia Pharmaceutical Drugs Market, Segmentation By Distribution Channel, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Billion)
  • 17.14 Australia Pharmaceutical Drugs Market, Segmentation By Route Of Administration, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Billion)
  • 17.15 Bangladesh Market
  • 17.16 Bangladesh Pharmaceutical Drugs Market, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Billion)
  • 17.17 China Market
  • 17.18 Summary
  • 17.19 Market Overview
    • 17.19.1 Country Information
    • 17.19.2 Market Information
    • 17.19.3 Background Information
    • 17.19.4 Government Initiatives
    • 17.19.5 Regulations
    • 17.19.6 Regulatory Bodies
    • 17.19.7 Major Associations
    • 17.19.8 Taxes Levied
    • 17.19.9 Corporate Tax Structure
    • 17.19.10 Investments
    • 17.19.11 Major Companies
  • 17.20 China Pharmaceutical Drugs Market, Segmentation By Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Billion)
  • 17.21 China Pharmaceutical Drugs Market, Segmentation By Distribution Channel, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Billion)
  • 17.22 China Pharmaceutical Drugs Market, Segmentation By Route Of Administration, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Billion)
  • 17.23 Hong Kong Market
  • 17.24 Hong Kong Pharmaceutical Drugs Market, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Billion)
  • 17.25 India Market
  • 17.26 India Pharmaceutical Drugs Market, Segmentation By Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Billion)
  • 17.27 India Pharmaceutical Drugs Market, Segmentation By Distribution Channel, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Billion)
  • 17.28 India Pharmaceutical Drugs Market, Segmentation By Route Of Administration, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Billion)
  • 17.29 Indonesia Market
  • 17.30 Indonesia Pharmaceutical Drugs Market, Segmentation By Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Billion)
  • 17.31 Indonesia Pharmaceutical Drugs Market, Segmentation By Distribution Channel, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Billion)
  • 17.32 Indonesia Pharmaceutical Drugs Market, Segmentation By Route Of Administration, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Billion)
  • 17.33 Japan Market
  • 17.34 Japan Pharmaceutical Drugs Market, Segmentation By Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Billion)
  • 17.35 Japan Pharmaceutical Drugs Market, Segmentation By Distribution Channel, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Billion)
  • 17.36 Japan Pharmaceutical Drugs Market, Segmentation By Route Of Administration, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Billion)
  • 17.37 Malaysia Market
  • 17.38 Malaysia Pharmaceutical Drugs Market, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Billion)
  • 17.39 New Zealand Market
  • 17.40 New Zealand Pharmaceutical Drugs Market, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Billion)
  • 17.41 Philippines Market
  • 17.42 Philippines Pharmaceutical Drugs Market, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Billion)
  • 17.43 Singapore Market
  • 17.44 Singapore Pharmaceutical Drugs Market, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Billion)
  • 17.45 South Korea Market
  • 17.46 South Korea Pharmaceutical Drugs Market, Segmentation By Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Billion)
  • 17.47 South Korea Pharmaceutical Drugs Market, Segmentation By Distribution Channel, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Billion)
  • 17.48 South Korea Pharmaceutical Drugs Market, Segmentation By Route Of Administration, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Billion)
  • 17.49 Thailand Market
  • 17.50 Thailand Pharmaceutical Drugs Market, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Billion)
  • 17.51 Vietnam Market
  • 17.52 Vietnam Pharmaceutical Drugs Market, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Billion)

18 Western Europe Market

  • 18.1 Summary
  • 18.2 Market Overview
    • 18.2.1 Region Information
    • 18.2.2 Market Information
    • 18.2.3 Background Information
    • 18.2.4 Government Initiatives
    • 18.2.5 Regulations
    • 18.2.6 Regulatory Bodies
    • 18.2.7 Major Associations
    • 18.2.8 Taxes Levied
    • 18.2.9 Corporate Tax Structure
    • 18.2.10 Investments
    • 18.2.11 Major Companies
  • 18.3 Western Europe Pharmaceutical Drugs Market, Segmentation By Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Billion)
  • 18.4 Western Europe Pharmaceutical Drugs Market, Segmentation By Distribution Channel, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Billion)
  • 18.5 Western Europe Pharmaceutical Drugs Market, Segmentation By Route Of Administration, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Billion)
  • 18.6 Western Europe Pharmaceutical Drugs Market, 2023, By Country, Value ($ Billion)
  • 18.7 Western Europe Pharmaceutical Drugs Market, 2018 - 2028, Historic And Forecast, By Country
  • 18.8 Western Europe Pharmaceutical Drugs Market, 2023 - 2028, Growth And Market Share Comparison, By Country
  • 18.9 Western Europe Pharmaceutical Drugs Market Metrics
    • 18.9.1 Per Capita Pharmaceutical Drugs Expenditure, 2023, Western Europe Major Countries
    • 18.9.2 Estimated Number Of Employees, Pharmaceutical Drugs Market, 2023, Western Europe Countries
  • 18.10 Western Europe Pharmaceutical Drugs Market: Country Analysis
  • 18.11 Austria Market
  • 18.12 Austria Pharmaceutical Drugs Market, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Billion)
  • 18.13 Belgium Market
  • 18.14 Belgium Pharmaceutical Drugs Market, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Billion)
  • 18.15 Denmark Market
  • 18.16 Denmark Pharmaceutical Drugs Market, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Billion)
  • 18.17 Finland Market
  • 18.18 Finland Pharmaceutical Drugs Market, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Billion)
  • 18.19 France Market
  • 18.20 France Pharmaceutical Drugs Market, Segmentation By Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Billion)
  • 18.21 France Pharmaceutical Drugs Market, Segmentation By Distribution Channel, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Billion)
  • 18.22 France Pharmaceutical Drugs Market, Segmentation By Route Of Administration, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Billion)
  • 18.23 Germany Market
  • 18.24 Germany Pharmaceutical Drugs Market, Segmentation By Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Billion)
  • 18.25 Germany Pharmaceutical Drugs Market, Segmentation By Distribution Channel, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Billion)
  • 18.26 Germany Pharmaceutical Drugs Market, Segmentation By Route Of Administration, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Billion)
  • 18.27 Ireland Market
  • 18.28 Ireland Pharmaceutical Drugs Market, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Billion)
  • 18.29 Italy Market
  • 18.30 Italy Pharmaceutical Drugs Market, Segmentation By Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Billion)
  • 18.31 Italy Pharmaceutical Drugs Market, Segmentation By Distribution Channel, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Billion)
  • 18.32 Italy Pharmaceutical Drugs Market, Segmentation By Route Of Administration, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Billion)
  • 18.33 Netherlands Market
  • 18.34 Netherlands Pharmaceutical Drugs Market, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Billion)
  • 18.35 Norway Market
  • 18.36 Norway Pharmaceutical Drugs Market, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Billion)
  • 18.37 Portugal Market
  • 18.38 Portugal Pharmaceutical Drugs Market, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Billion)
  • 18.39 Spain Market
  • 18.40 Spain Pharmaceutical Drugs Market, Segmentation By Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Billion)
  • 18.41 Spain Pharmaceutical Drugs Market, Segmentation By Distribution Channel, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Billion)
  • 18.42 Spain Pharmaceutical Drugs Market, Segmentation By Route Of Administration, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Billion)
  • 18.43 Sweden Market
  • 18.44 Sweden Pharmaceutical Drugs Market, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Billion)
  • 18.45 Switzerland Market
  • 18.46 Switzerland Pharmaceutical Drugs Market, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Billion)
  • 18.47 UK Market
  • 18.48 UK Pharmaceutical Drugs Market, Segmentation By Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Billion)
  • 18.49 UK Pharmaceutical Drugs Market, Segmentation By Distribution Channel, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Billion)
  • 18.50 UK Pharmaceutical Drugs Market, Segmentation By Route Of Administration, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Billion)

19 Eastern Europe Market

  • 19.1 Summary
  • 19.2 Market Overview
    • 19.2.1 Region Information
    • 19.2.2 Market Information
    • 19.2.3 Background Information
    • 19.2.4 Government Initiatives
    • 19.2.5 Regulations
    • 19.2.6 Regulatory Bodies
    • 19.2.7 Major Associations
    • 19.2.8 Taxes Levied
    • 19.2.9 Corporate Tax Structure
    • 19.2.10 Investments
    • 19.2.11 Major Companies
  • 19.3 Eastern Europe Pharmaceutical Drugs Market, Segmentation By Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Billion)
  • 19.4 Eastern Europe Pharmaceutical Drugs Market, Segmentation By Distribution Channel, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Billion)
  • 19.5 Eastern Europe Pharmaceutical Drugs Market, Segmentation By Route Of Administration, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Billion)
  • 19.6 Eastern Europe Pharmaceutical Drugs Market, 2023, By Country, Value ($ Billion)
  • 19.7 Eastern Europe Pharmaceutical Drugs Market, 2018 - 2028, Historic And Forecast, By Country
  • 19.8 Eastern Europe Pharmaceutical Drugs Market, 2023 - 2028, Growth And Market Share Comparison, By Country
  • 19.9 Eastern Europe Pharmaceutical Drugs Market Metrics
    • 19.9.1 Per Capita Pharmaceutical Drugs Expenditure, 2023, Eastern Europe Major Countries
    • 19.9.2 Estimated Number Of Employees, Pharmaceutical Drugs Market, 2023, Eastern Europe Countries
  • 19.10 Eastern Europe Pharmaceutical Drugs Market: Country Analysis
  • 19.11 Czech Republic Market
  • 19.12 Czech Republic Pharmaceutical Drugs Market, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Billion)
  • 19.13 Poland Market
  • 19.14 Poland Pharmaceutical Drugs Market, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Billion)
  • 19.15 Romania Market
  • 19.16 Romania Pharmaceutical Drugs Market, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Billion)
  • 19.17 Russia Market
  • 19.18 Russia Pharmaceutical Drugs Market, Segmentation By Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Billion)
  • 19.19 Russia Pharmaceutical Drugs Market, Segmentation By Distribution Channel, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Billion)
  • 19.20 Russia Pharmaceutical Drugs Market, Segmentation By Route Of Administration, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Billion)
  • 19.21 Ukraine Market
  • 19.22 Ukraine Pharmaceutical Drugs Market, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Billion)

20 North America Market

  • 20.1 Summary
  • 20.2 Market Overview
    • 20.2.1 Region Information
    • 20.2.2 Market Information
    • 20.2.3 Background Information
    • 20.2.4 Government Initiatives
    • 20.2.5 Regulations
    • 20.2.6 Regulatory Bodies
    • 20.2.7 Major Associations
    • 20.2.8 Taxes Levied
    • 20.2.9 Corporate Tax Structure
    • 20.2.10 Investments
    • 20.2.11 Major Companies
  • 20.3 North America Pharmaceutical Drugs Market, Segmentation By Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Billion)
  • 20.4 North America Pharmaceutical Drugs Market, Segmentation By Distribution Channel, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Billion)
  • 20.5 North America Pharmaceutical Drugs Market, Segmentation By Route Of Administration, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Billion)
  • 20.6 North America Pharmaceutical Drugs Market, 2023, By Country, Value ($ Billion)
  • 20.7 North America Pharmaceutical Drugs Market, 2018 - 2028, Historic And Forecast, By Country
  • 20.8 North America Pharmaceutical Drugs Market, 2023 - 2028, Growth And Market Share Comparison, By Country
  • 20.9 North America Pharmaceutical Drugs Market Metrics
    • 20.9.1 Per Capita Pharmaceutical Drugs Expenditure, 2023, North America Major Countries
    • 20.9.2 Estimated Number Of Employees, Pharmaceutical Drugs Market, 2023, North America Countries
  • 20.10 North America Pharmaceutical Drugs Market: Country Analysis
  • 20.11 Canada Market
  • 20.12 Canada Pharmaceutical Drugs Market, Segmentation By Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Billion)
  • 20.13 Canada Pharmaceutical Drugs Market, Segmentation By Distribution Channel, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Billion)
  • 20.14 Canada Pharmaceutical Drugs Market, Segmentation By Route Of Administration, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Billion)
  • 20.15 Mexico Market
  • 20.16 Mexico Pharmaceutical Drugs Market, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Billion)
  • 20.17 USA Market
  • 20.18 Summary
  • 20.19 Market Overview
    • 20.19.1 Country Information
    • 20.19.2 Market Information
    • 20.19.3 Background Information
    • 20.19.4 Government Initiatives
    • 20.19.5 Regulations
    • 20.19.6 Regulatory Bodies
    • 20.19.7 Major Associations
    • 20.19.8 Taxes Levied
    • 20.19.9 Corporate Tax Structure
    • 20.19.10 Investments
    • 20.19.11 Major Companies
  • 20.20 USA Pharmaceutical Drugs Market, Segmentation By Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Billion)
  • 20.21 USA Pharmaceutical Drugs Market, Segmentation By Distribution Channel, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Billion)
  • 20.22 USA Pharmaceutical Drugs Market, Segmentation By Route Of Administration, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Billion)

21 South America Market

  • 21.1 Summary
  • 21.2 Market Overview
    • 21.2.1 Region Information
    • 21.2.2 Market Information
    • 21.2.3 Background Information
    • 21.2.4 Government Initiatives
    • 21.2.5 Regulations
    • 21.2.6 Regulatory Bodies
    • 21.2.7 Major Associations
    • 21.2.8 Taxes Levied
    • 21.2.9 Corporate Tax Structure
    • 21.2.10 Investments
    • 21.2.11 Major Companies
  • 21.3 South America Pharmaceutical Drugs Market, Segmentation By Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Billion)
  • 21.4 South America Pharmaceutical Drugs Market, Segmentation By Distribution Channel, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Billion)
  • 21.5 South America Pharmaceutical Drugs Market, Segmentation By Route Of Administration, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Billion)
  • 21.6 South America Pharmaceutical Drugs Market, 2023, By Country, Value ($ Billion)
  • 21.7 South America Pharmaceutical Drugs Market, 2018 - 2028, Historic And Forecast, By Country
  • 21.8 South America Pharmaceutical Drugs Market, 2023 - 2028, Growth And Market Share Comparison, By Country
  • 21.9 South America Pharmaceutical Drugs Market Metrics
    • 21.9.1 Per Capita Pharmaceutical Drugs Expenditure, 2023, South America Major Countries
    • 21.9.2 Estimated Number Of Employees, Pharmaceutical Drugs Market, 2023, South America Countries
  • 21.10 South America Pharmaceutical Drugs Market: Country Analysis
  • 21.11 Argentina Market
  • 21.12 Argentina Pharmaceutical Drugs Market, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Billion)
  • 21.13 Brazil Market
  • 21.14 Brazil Pharmaceutical Drugs Market, Segmentation By Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Billion)
  • 21.15 Brazil Pharmaceutical Drugs Market, Segmentation By Distribution Channel, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Billion)
  • 21.16 Brazil Pharmaceutical Drugs Market, Segmentation By Route Of Administration, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Billion)
  • 21.17 Chile Market
  • 21.18 Chile Pharmaceutical Drugs Market, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Billion)
  • 21.19 Colombia Market
  • 21.20 Colombia Pharmaceutical Drugs Market, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Billion)
  • 21.21 Peru Market
  • 21.22 Peru Pharmaceutical Drugs Market, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Billion)

22 Middle East Market

  • 22.1 Summary
  • 22.2 Market Overview
    • 22.2.1 Region Information
    • 22.2.2 Market Information
    • 22.2.3 Background Information
    • 22.2.4 Government Initiatives
    • 22.2.5 Regulations
    • 22.2.6 Regulatory Bodies
    • 22.2.7 Major Associations
    • 22.2.8 Taxes Levied
    • 22.2.9 Corporate Tax Structure
    • 22.2.10 Investments
    • 22.2.11 Major Companies
  • 22.3 Middle East Pharmaceutical Drugs Market, Segmentation By Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Billion)
  • 22.4 Middle East Pharmaceutical Drugs Market, Segmentation By Distribution Channel, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Billion)
  • 22.5 Middle East Pharmaceutical Drugs Market, Segmentation By Route Of Administration, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Billion)
  • 22.6 Middle East Pharmaceutical Drugs Market, 2023, By Country, Value ($ Billion)
  • 22.7 Middle East Pharmaceutical Drugs Market, 2018 - 2028, Historic And Forecast, By Country
  • 22.8 Middle East Pharmaceutical Drugs Market, 2023 - 2028, Growth And Market Share Comparison, By Country
  • 22.9 Middle East Pharmaceutical Drugs Market Metrics
    • 22.9.1 Per Capita Pharmaceutical Drugs Expenditure, 2023, Middle East Major Countries
    • 22.9.2 Estimated Number Of Employees, Pharmaceutical Drugs Market, 2023, Middle East Countries
  • 22.10 Middle East Pharmaceutical Drugs Market: Country Analysis
  • 22.11 Iran Market
  • 22.12 Iran Pharmaceutical Drugs Market, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Billion)
  • 22.13 Israel Market
  • 22.14 Israel Pharmaceutical Drugs Market, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Billion)
  • 22.15 Saudi Arabia Market
  • 22.16 Saudi Arabia Pharmaceutical Drugs Market, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Billion)
  • 22.17 Turkey Market
  • 22.18 Turkey Pharmaceutical Drugs Market, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Billion)
  • 22.19 UAE Market
  • 22.20 UAE Pharmaceutical Drugs Market, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Billion)

23 Africa Market

  • 23.1 Summary
  • 23.2 Market Overview
    • 23.2.1 Region Information
    • 23.2.2 Market Information
    • 23.2.3 Background Information
    • 23.2.4 Government Initiatives
    • 23.2.5 Regulations
    • 23.2.6 Regulatory Bodies
    • 23.2.7 Major Associations
    • 23.2.8 Taxes Levied
    • 23.2.9 Corporate Tax Structure
    • 23.2.10 Investments
    • 23.2.11 Major Companies
  • 23.3 Africa Pharmaceutical Drugs Market, Segmentation By Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Billion)
  • 23.4 Africa Pharmaceutical Drugs Market, Segmentation By Distribution Channel, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Billion)
  • 23.5 Africa Pharmaceutical Drugs Market, Segmentation By Route Of Administration, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Billion)
  • 23.6 Africa Pharmaceutical Drugs Market, 2023, By Country, Value ($ Billion)
  • 23.7 Africa Pharmaceutical Drugs Market, 2018 - 2028, Historic And Forecast, By Country
  • 23.8 Africa Pharmaceutical Drugs Market, 2023 - 2028, Growth And Market Share Comparison, By Country
  • 23.9 Africa Pharmaceutical Drugs Market Metrics
    • 23.9.1 Per Capita Pharmaceutical Drugs Expenditure, 2023, Africa Major Countries
    • 23.9.2 Estimated Number Of Employees, Pharmaceutical Drugs Market, 2023, Africa Countries
  • 23.10 Africa Pharmaceutical Drugs Market: Country Analysis
  • 23.11 Egypt Market
  • 23.12 Egypt Pharmaceutical Drugs Market, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Billion)
  • 23.13 Nigeria Market
  • 23.14 Nigeria Pharmaceutical Drugs Market, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Billion)
  • 23.15 South Africa Market
  • 23.16 South Africa Pharmaceutical Drugs Market, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Billion)

24 Competitive Landscape And Company Profiles

  • 24.1 Company Profiles
  • 24.2 Pfizer Inc
    • 24.2.1 Company Overview
    • 24.2.2 Products And Services
    • 24.2.3 Business Strategy
    • 24.2.4 Financial Overview
  • 24.3 Johnson & Johnson
    • 24.3.1 Company Overview
    • 24.3.2 Products And Services
    • 24.3.3 Business Strategy
    • 24.3.4 Financial Overview
  • 24.4 AbbVie Inc
    • 24.4.1 Company Overview
    • 24.4.2 Products And Services
    • 24.4.3 Business Strategy
    • 24.4.4 Financial Overview
  • 24.5 Merck & Co., Inc.
    • 24.5.1 Company Overview
    • 24.5.2 Products And Services
    • 24.5.3 Business Strategy
    • 24.5.4 Financial Overview
  • 24.6 F. Hoffman-La Roche Ltd
    • 24.6.1 Company Overview
    • 24.6.2 Products And Services
    • 24.6.3 Business Strategy
    • 24.6.4 Financial Overview

25 Other Major And Innovative Companies

  • 25.1 AstraZeneca Plc
    • 25.1.1 Company Overview
    • 25.1.2 Products And Services
  • 25.2 Novartis AG
    • 25.2.1 Company Overview
    • 25.2.2 Products And Services
  • 25.3 Bristol-Myers Squibb Company
    • 25.3.1 Company Overview
    • 25.3.2 Products And Services
  • 25.4 Sanofi S.A
    • 25.4.1 Company Overview
    • 25.4.2 Products And Services
  • 25.5 GSK plc
    • 25.5.1 Company Overview
    • 25.5.2 Products And Services
  • 25.6 Novo Nordisk A/S
    • 25.6.1 Company Overview
    • 25.6.2 Products And Services
  • 25.7 Eli Lilly and Company
    • 25.7.1 Company Overview
    • 25.7.2 Products And Services
  • 25.8 Takeda Pharmaceutical Company Limited
    • 25.8.1 Company Overview
    • 25.8.2 Products And Services
  • 25.9 Amgen Inc
    • 25.9.1 Company Overview
    • 25.9.2 Products And Services
  • 25.10 Gilead Sciences Inc
    • 25.10.1 Company Overview
    • 25.10.2 Products And Services
  • 25.11 C.H. Boehringer Sohn AG & Co. KG
    • 25.11.1 Company Overview
    • 25.11.2 Products And Services
  • 25.12 Bayer AG
    • 25.12.1 Company Overview
    • 25.12.2 Products And Services
  • 25.13 Teva Pharmaceutical Industries Ltd
    • 25.13.1 Company Overview
    • 25.13.2 Products And Services
  • 25.14 CSL Limited
    • 25.14.1 Company Overview
    • 25.14.2 Products And Services
  • 25.15 Daiichi Sankyo Company, Limited
    • 25.15.1 Company Overview
    • 25.15.2 Products And Services

26 Competitive Benchmarking

27 Competitive Dashboard

28 Key Mergers And Acquisitions

  • 28.1 Ceres Pharma NV Acquired Innopharm Kft
  • 28.2 Abbott Laboratories Acquired Bigfoot Biomedical
  • 28.3 Novo Nordisk Acquired Inversago Pharma
  • 28.4 Biogen Acquired Reata Pharmaceuticals
  • 28.5 Eli Lilly Acquired Dice Therapeutics
  • 28.6 Recursion Pharmaceuticals Acquired Cyclica and Valance
  • 28.7 GSK Acquired Bellus Health
  • 28.8 Sanofi Acquired Provention Bio
  • 28.9 Pfizer Acquired Seagen
  • 28.10 Leap Therapeutics, Inc. Merged With Flame Biosciences, Inc.
  • 28.11 Sun Pharmaceutical Industries Acquired Concert Pharma
  • 28.12 GSK PLC Acquired Sierra Oncology Inc
  • 28.13 Bora Pharmaceuticals Acquired Eden Biologics
  • 28.14 GSK plc Acquired Affinivax, Inc
  • 28.15 Piramal Pharma Acquired Hemmo Pharmaceuticals
  • 28.16 Ethypharm Acquired Altan Pharma
  • 28.17 Jazz Pharmaceuticals Acquired GW Pharmaceuticals Plc
  • 28.18 Sanofi SA Acquired Tidal Therapeutics
  • 28.19 Merck & Co Acquired Pandion Therapeutics
  • 28.20 Horizon Therapeutics Acquired Viela Bio

29 Opportunities And Strategies

  • 29.1 Global Pharmaceutical Drugs Market In 2028 - Countries Offering Most New Opportunities
  • 29.2 Global Pharmaceutical Drugs Market In 2028 - Segments Offering Most New Opportunities
  • 29.3 Global Pharmaceutical Drugs Market In 2028 - Growth Strategies
    • 29.3.1 Market Trend Based Strategies
    • 29.3.2 Competitor Strategies

30 Pharmaceutical Drugs Market, Conclusions And Recommendations

  • 30.1 Conclusions
  • 30.2 Recommendations
    • 30.2.1 Product
    • 30.2.2 Place
    • 30.2.3 Price
    • 30.2.4 Promotion
    • 30.2.5 People

31 Appendix

  • 31.1 Geographies Covered
  • 31.2 Market Data Sources
  • 31.3 Research Methodology
  • 31.4 Currencies
  • 31.5 The Business Research Company
  • 31.6 Copyright and Disclaimer